Verve Therapeutics's total assets for Q4 2024 were $647.39M, a decrease of -2.49% from the previous quarter. VERV total liabilities were $153.99M for the fiscal quarter, a -0.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.